Replies to post #111129 on Biotech Values

[ghmm]

GENZ:

The webcast is still not available but the slides are at
http://www.genzyme.com/corp/investors/AlemtuzumabInvestorEvent.pdf
slides 21-25 are an interesting comparison against ifn-b

and there are a couple of video's on the MOA/MS Progression at
http://www.genzyme.com/corp/investors/inv_home.asp

[DewDiligence]

GENZ’s claim of $3-3.5B peak sales for Campath lacks credibility, IMHO:

http://finance.yahoo.com/news/Genzyme-Details-Market-bw-1655525372.html?x=0&.v=1